On #WLAD we recognize challenges patients face post-treatment: ~30% of #DLBCL patients relapse, often taking 1–2 years to confirm with current methods. Foresight CLARITY™ seeks to detect relapse sooner, enabling precise care. Learn more: bit.ly/45yFqgO #BloodCancerMonth